Becker's Healthcare October 15, 2024
Alexandra Murphy

A new survey by the National Community Pharmacists Association found that more than 90% of independent pharmacists may refuse to sell drugs targeted by Medicare Part D negotiations, potentially jeopardizing the Biden administration’s efforts to lower prescription costs.

The survey, conducted from Sept. 24 to Oct. 11, found that 51% of pharmacists are strongly considering not stocking drugs due to inadequate reimbursements from pharmacy benefit managers, with another 40% considering the same, according...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech, Survey / Study, Trends
CVS, Walgreens & Walmart's healthcare strategy faces headwinds: 10 notes from 2024
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Mark Cuban's 2025 plans
Pharma At A Crossroads: Navigating Cost Pressures And Regulatory Shifts In 2025

Share This Article